Today, the Food and Drug Administration (FDA) approved Pfizer boosters for 12- to 15-year-olds as schools reopen after the holiday break amid the omicron surge.
In a release, the FDA also said it has amended the emergency use authorization for the Pfizer vaccine to also shorten the time between the completion of primary vaccination of the Pfizer vaccine and a booster dose to at least five months, instead of six, and to allow for a third dose for certain immunocompromised children 5 through 11 years of age.
The agency said it had determined that the protective health benefits and the "continued protection against COVID-19 and the associated serious consequences that can occur including hospitalization and death, outweigh the potential risks in individuals 12 through 15 years of age."
Please select this link to read the complete article from ABC News.